Body

ANN ARBOR, Mich. -- More than half of adults believe children today are more stressed, experience less quality family time and have worse mental and emotional health than children in past generations, according to the C.S. Mott Children's Hospital National Poll on Children's Health.

A University of Colorado Cancer Center study presented at the American Association for Cancer Research Annual Meeting 2016 demonstrates the use of gas microbubbles to selectively attach to and float circulating tumor cells from blood samples, allowing analysis of the isolated cells.

A University of Colorado Cancer Center study presented at the American Association for Cancer Research Annual Meeting 2016 pinpoints ways that cancer cells evolve to resist the drug LOXO-101, a kinase inhibitor of the TRK-fusion genes that drive a subset of cancers. The drug is currently being evaluated in promising phase 1 and phase 2 clinical trials.

COLUMBUS, Ohio -- Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet-B (UVB) light delayed melanoma onset in a mouse model of the disease, according to data from a team at The Ohio State University Comprehensive Cancer Center Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. This data suggest that the mouse model can be used to identify new, more effective melanoma-preventing agents, according to principal investigator Christin Burd, PhD.

A phase I study of the drug LOXO-101 appears to significantly reduce tumors in patients with varied types of genetically defined cancer, according to a study led by The University of Texas MD Anderson Cancer Center.

The results of the study, which followed patients with unique proteins called tropomyosin receptor kinase fusions (TRKs), were presented at the American Association for Cancer Research's annual meeting held April 16-20 in New Orleans.

ANN ARBOR, Mich. -- Some say there's always room for dessert - but those who follow that motto young may be more likely to gain unhealthy weight, a new study suggests.

Toddlers who reached for cookies over chips when their bellies were full had a higher risk of body fat increases, University of Michigan researchers report in the May issue of Pediatrics.

Encountering information suggesting that it may be tough to find a romantic partner shifts people's decision making toward riskier options, according to new findings from a series of studies published in Psychological Science, a journal of the Association for Psychological Science.

Malaga, Spain - April 17, 2016 - Today, at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, an international research team presented the preliminary results of a new study which aimed to determine whether the predictive value of a past major osteoporotic fracture (MOF) for future MOF changed with time.

They studied a database of 118,872 men and women born between 1907 and 1935 who were part of the Reykjavik Study during 1967-1991. Data on all fractures from participant entry into the study until December 31, 2012 were extracted.

Researchers from the Sahlgrenska Academy in Molndal, Sweden have published preliminary results of a fracture risk study, which was based on analysis of medical records from 1987 to 2002 covering the entire Swedish population born between 1902 and 1952.

UK researchers have presented a new study that supports the cardiovascular safety of calcium and vitamin D supplementation. The study was based on analysis of the UK Biobank, a very large study comprising 502,664 men and women aged 40-69 years.

Today, at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. researchers from the University of Liège, Belgium presented a study that reveals the enormous and growing burden of sarcopenia in Europe.

Sarcopenia is a disease associated with the ageing process. Hallmark signs of the disorder are loss of muscle mass and strength, which in turn affects balance, gait and overall ability to perform tasks of daily living.

April 16, 2016, Barcelona, Spain: New data presented today confirms that a novel first-in-class treatment for Hepatitis B, called NVR 3-778, is well-tolerated and can reduce levels of the virus' genetic material in the body when combined with pegylated interferon after four weeks of treatment. The updated Phase 1b trial results were presented today at The International Liver CongressTM 2016 in Barcelona, Spain.

NEW ORLEANS - Women who stayed on a low fat diet for approximately eight years reduced their risk of death from invasive breast cancers and improved their survival rates when compared with women who had not followed the dietary regimen, according to a study presented at a clinical trial plenary session, entitled "Transformative Clinical Trials in Breast Cancer," at the American Association for Cancer Research (AACR) annual meeting.

In a small, phase I clinical trial, Johns Hopkins Kimmel Cancer Center researchers say they show for the first time that the experimental drug guadecitabine (SGI-110) is safe in combination with the chemotherapy drug irinotecan and may overcome resistance to irinotecan in patients with metastatic colorectal cancer. Results of the study are expected to be presented April 17 at the American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans (abstract CT017).

St. Jude Children's Research Hospital research related to survivorship, precision medicine and a wide range of other topics will be presented and highlighted during the five-day American Association for Cancer Research (AACR) annual meeting that begins Saturday in New Orleans.